About Icon Bioscience
Icon Bioscience is a company based in Sunnyvale (United States) founded in 2004 was acquired by EyePoint Pharmaceuticals in March 2018.. Icon Bioscience has raised $37.32 million across 3 funding rounds from investors including EyePoint Pharmaceuticals. Icon Bioscience offers products and services including Prescription Medications and Online Pharmacy Services.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name My Canadian Pharmacy
-
Annual Revenue
$00as on Dec 01, 2015
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37.32 M (USD)
in 3 rounds
-
Latest Funding Round
$5.32 M (USD), Series B
Dec 01, 2015
- Investors
-
Employee Count
Employee Count
-
Acquired by
EyePoint Pharmaceuticals
(Mar 28, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Icon Bioscience
Icon Bioscience offers a comprehensive portfolio of products and services, including Prescription Medications and Online Pharmacy Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Various prescription drugs are sold for conditions such as erectile dysfunction and asthma.
Services including prescription refills and transfers are offered to support customer access to medications.
Funding Insights of Icon Bioscience
Icon Bioscience has successfully raised a total of $37.32M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.32 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $5.3M
-
First Round
First Round
(01 Jun 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Series B - Icon Bioscience | Valuation |
investors |
|
| Aug, 2013 | Amount | Series B - Icon Bioscience | Valuation |
investors |
|
| Jun, 2013 | Amount | Series A - Icon Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Icon Bioscience
Icon Bioscience has secured backing from 1 investor. Prominent investors backing the company include EyePoint Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecule therapeutics for ophthalmic disorders are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Icon Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Icon Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Icon Bioscience Comparisons
Competitors of Icon Bioscience
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Icon Bioscience
Frequently Asked Questions about Icon Bioscience
When was Icon Bioscience founded?
Icon Bioscience was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Where is Icon Bioscience located?
Icon Bioscience is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Icon Bioscience a funded company?
Icon Bioscience is a funded company, having raised a total of $37.32M across 3 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Jun 01, 2013.
What does Icon Bioscience do?
Icon Bioscience was established in 2004 in Sunnyvale, United States, operating as an online pharmacy in the healthcare sector. Medications for conditions such as erectile dysfunction, birth control, asthma, and pain relief are sourced directly from manufacturers with emphasis on quality control and proper storage. Existing prescriptions can be transferred or refilled by customers, including as guests, while a search function aids product location. Pharmacist consultations are available for inquiries.
What products or services does Icon Bioscience offer?
Icon Bioscience offers Prescription Medications and Online Pharmacy Services.
Who are Icon Bioscience's investors?
Icon Bioscience has 1 investor. Key investors include EyePoint Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.